Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNTech SE - ADR (BNTX) vs J B Hunt Transport Services Inc (JBHT) Price & Performance

BioNTech SE - ADRTrade
J B Hunt Transport Services IncTrade

Price performance (Past 24H)

Key statistics

BioNTech SE - ADR vs J B Hunt Transport Services Inc — how do they compare? BioNTech SE - ADR trades at $89.89 (market cap $22.86B), while J B Hunt Transport Services Inc trades at $281 (market cap $26.49B). The key difference: J B Hunt Transport Services Inc is the larger of the two by market cap, and J B Hunt Transport Services Inc pays a 0.64% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.

BNTXJBHT
Market Cap
$22.86B$26.49B
Sector
HealthIndustrials
52-Week High
$119.34$290.07
52-Week Low
$83.89$130.65
Enterprise Value
$6.53B$27.78B
Dividend Yield
0.64%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BioNTech SE - ADR

BioNTech (BNTX) trades at $90.07, down 1.55% today, amid a bearish technical signal and declining revenue trends. The company reported a net loss of $1.14 billion in 2025, with profitability metrics negative, though it maintains a strong cash position of $16.78 billion. Recent news highlights restructuring efforts, including site closures and a $1 billion share buyback, as it pivots focus to oncology pipeline development following reduced COVID-19 vaccine demand.

The outlook remains challenging with persistent losses and competitive pressures, but analyst consensus is bullish with a $129.67 price target. Key risks include execution of the oncology strategy and revenue volatility. The stock's current valuation reflects uncertainty, offering potential upside if pipeline milestones are met, but investors face significant operational and market headwinds.

J B Hunt Transport Services Inc

JB Hunt Transport Services (JBHT) trades at $283.00, up 1.09% with a bullish technical signal from moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected soon. Valuation metrics show a P/E of 43.95 and P/S of 2.25, while profitability remains solid with 5.13% net margin and 16.68% ROE. Analyst consensus is strongly positive with 26 buy ratings and a $280.59 price target.

JBHT demonstrates consistent operational performance with stable cash flow generation, though revenue has declined from 2022 peaks. The stock faces valuation concerns with elevated P/E ratios, while freight market cyclicality presents ongoing business risks. Earnings momentum and strong analyst support provide upside potential, but investors should monitor Q2 earnings results for confirmation of growth trajectory.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX

About J B Hunt Transport Services Inc

J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).

Read more on JBHT